These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16188682)

  • 1. Late effects of hematopoietic stem cell transplantation.
    Kansu E
    Hematology; 2005; 10 Suppl 1():238-44. PubMed ID: 16188682
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.
    Bieri S; Roosnek E; Ozsahin H; Huguet S; Ansari M; Trombetti A; Helg C; Chapuis B; Miralbell R; Passweg J; Chalandon Y
    Eur J Haematol; 2011 Aug; 87(2):138-47. PubMed ID: 21535161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late complications in blood and marrow transplant survivors.
    Majhail NS
    Minn Med; 2010 Oct; 93(10):45-9. PubMed ID: 21140762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thirty-six-year-old woman submitted to autogenic transplantation of peripheral blood due to breast neoplasm with fever and generalized cutaneous lesions].
    Montes A; Palou J; Martín E
    Med Clin (Barc); 2000 Sep; 115(8):313-8. PubMed ID: 11093888
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematopoietic stem cell transplantation].
    Sato N
    Rinsho Byori; 2001 Mar; Suppl 115():103-10. PubMed ID: 11391926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation.
    Adelberg DE; Bishop MR
    Emerg Med Clin North Am; 2009 May; 27(2):311-31. PubMed ID: 19447314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral malignancies following HSCT: graft versus host disease and other risk factors.
    Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
    Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M; Dhedin N; Michallet AS
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute graft-versus-host disease following hematopoietic stem-cell transplantation.
    Hu SW; Cotliar J
    Dermatol Ther; 2011; 24(4):411-23. PubMed ID: 21910799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation.
    Liu Z; Peng Y; Yong X; Mei G; Yang Y; Yi C; Tao R
    Oral Oncol; 2020 Oct; 109():104629. PubMed ID: 32165139
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular graft vs. host disease after hematopoietic stem cell transplantation.
    Rumery TC; Mian SI
    Insight; 2013; 38(1):11-8. PubMed ID: 23505793
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
    Nishi T; Okazaki K; Fujii S; Uchida K; Uose S; Nakase H; Ohana M; Nishihara T; Chiba T
    Endoscopy; 2001 Nov; 33(11):985-7. PubMed ID: 11668409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications of hematopoietic stem cell transplantation: physiopathology and management. 2. Graft-versus-host disease (GVHD)].
    Morishita Y
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1502-9. PubMed ID: 9780678
    [No Abstract]   [Full Text] [Related]  

  • 16. Levels of insulin-like growth factor after stem cell transplantation.
    Munker R; Salat C; Pihusch R; Diem H; Hiller E; Glass J; Kolb HJ; Yu H
    Eur J Med Res; 2001 Apr; 6(4):181-4. PubMed ID: 11309231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current update on reduced intensity regimens for allogeneic stem cell transplantation.
    Blaise D; Mohty M; Faucher C; Olive D; Chabannon C
    Hematology; 2005; 10 Suppl 1():64-5. PubMed ID: 16188639
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction to graft-versus-host disease.
    Ringdén O
    Biol Blood Marrow Transplant; 2005 Feb; 11(2 Suppl 2):17-20. PubMed ID: 15682170
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous graft-versus-host disease.
    Hess AD
    J Hematother Stem Cell Res; 2000 Jun; 9(3):297. PubMed ID: 10894350
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
    Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.